We must chart a course that continues producing robust mortality gains absolutely critical to our bottom lines … despite the challenges posed by the incipient 2020 Great Recession and the protean consequences of the COVID-19 pandemic. This article identifies and discusses core factors that I believe will determine how all of this sorts out over the next decade. It also suggests how we can greatly minimize mortality-related adversities via prudent changes in how we underwrite life insurance.

Mortality results are of paramount importance to your bottom line. Here, a seasoned industry expert explains what the current situation is, why we are where we are, and how we can survive.

Life and Health Insurance Underwriting is entering a “new normal”. The industry is moving beyond exploring new technologies, such as advanced data analytics and automation, to real-world applications. In this new environment, innovation is not seen as novel but as critical to the success of the insurance enterprise. Insurers are taking tangible steps to fundamentally change the ways that global life and health risks are underwritten.